{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:37:46Z","timestamp":1790739466074,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/bjc.2017.269","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T22:47:20Z","timestamp":1503010040000},"page":"1341-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Evaluating the effect of immune cells on the outcome of patients with mesothelioma"],"prefix":"10.1038","volume":"117","author":[{"given":"Serena J","family":"Chee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Mellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmali","family":"Gankande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karwan A","family":"Moutasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandurangan","family":"Vijayanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H","family":"Ottensmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"issue":"5","key":"BFbjc2017269_CR1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","volume":"18","author":"EW Alley","year":"2017","unstructured":"Alley EW, Lopez J, Santoro A, Morosky A, Saraf S, Piperdi B, van Brummelen E (2017) Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial. Lancet Onco 18 (5): 623\u2013630.","journal-title":"Lancet Onco"},{"issue":"16","key":"BFbjc2017269_CR2","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","volume":"14","author":"KI Al Shibli","year":"2008","unstructured":"Al Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT (2008) Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small-cell lung cancer. Clin Cancer Res 14 (16): 5220\u20135227.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"BFbjc2017269_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jtcvs.2007.10.026","volume":"135","author":"M Anraku","year":"2008","unstructured":"Anraku M, Cunningham KS, Yun Z, Tsao MS, Zhang L, Keshavjee S, Johnston MR, de Perrot M (2008) Impact of tumour-infiltrating T-cells on survival in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 135 (4): 823\u2013829.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"BFbjc2017269_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1158\/2326-6066.CIR-16-0171","volume":"4","author":"MM Awad","year":"2016","unstructured":"Awad MM, Jones RE, Liu H, Lizotte PH, Ivanova EV, Kulkarni M, Herter-Sprie GS, Liao X, Santos AA, Bittinger MA, Keogh L, Koyama S, Almonte C, English JM, Barlow J, Richards WG, Barbie DA, Bass AJ, Rodig SJ, Hodi FS, Wucherpfennig KW, J\u00e4nne PA, Sholl LM, Hammerman PS, Wong KK, Bueno R (2016) Cytotoxic T cells in PD-L1 positive malignant pleural mesotheliomas are counterbalanced by distinct immunosuppressive factors. Cancer Immunol Res 4 (12): 1038\u20131048.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"BFbjc2017269_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","volume":"12","author":"C Badoual","year":"2006","unstructured":"Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay NEH, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E (2006) Prognostic value of tumour-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12 (2): 465\u2013472.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"BFbjc2017269_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/cr.2013.155","volume":"24","author":"Y Bao","year":"2014","unstructured":"Bao Y, Liu X, Han C, Xu S, Xie B, Zhang Q, Gu Y, Hou J, Qian L, Qian C, Han H, Cau X (2014) Identification of INF-\u03b3-producing innate B cells. Cell Res 24 (2): 161\u2013176.","journal-title":"Cell Res"},{"issue":"1","key":"BFbjc2017269_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2901","volume":"11","author":"N Baumgarth","year":"2011","unstructured":"Baumgarth N (2011) The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 11 (1): 34\u201346.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"BFbjc2017269_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pag\u00e8s F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoural immune cells reveal the immune landscape in human cancer. Immunity 39 (4): 782\u2013795.","journal-title":"Immunity"},{"issue":"11","key":"BFbjc2017269_CR9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00262-011-1103-6","volume":"60","author":"AJ Bograd","year":"2011","unstructured":"Bograd AJ, Suzuki K, Vertes E, Colovos C, Morales EA, Sadelain M, Adusumilli PS (2011) Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma. Cancer Immunol Immunother 60 (11): 1509\u20131527.","journal-title":"Cancer Immunol Immunother"},{"issue":"23","key":"BFbjc2017269_CR10","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1158\/1078-0432.CCR-14-1622","volume":"20","author":"JR Brown","year":"2014","unstructured":"Brown JR, Wimberly H, Lannin DR, Nixon C, Rimm DL, Bossuyt V (2014) Multiplexed quantitative analysis of CD3, CD8 and CD20 predicts response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res 20 (23): 5995\u20136005.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"BFbjc2017269_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, Gnad F, Nguyen TT, Jaiswal BS, Chirieac LR, Sciaranghella D, Dao N, Gustafson CE, Munir KJ, Hackney JA, Chaudhuri A, Gupta R, Guillory J, Toy K, Ha C, Chen YJ, Stinson J, Chaudhuri S, Zhang N, Wu TD, Sugarbaker DJ, de Sauvage FJ, Richards WG, Seshagiri S (2016) Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet 48 (4): 407\u2013416.","journal-title":"Nat Genet"},{"issue":"11","key":"BFbjc2017269_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S1470-2045(13)70381-4","volume":"14","author":"L Calabr\u00f2","year":"2013","unstructured":"Calabr\u00f2 L, Morra A, Fonsatti E, Cutaia O, Amato G, Giannarelli D, Di Giacomo AM, Danielli R, Altomonte M, Mutti L, Maio M (2013) Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open label, single-arm, phase 2 trial. Lancet Oncol 14 (11): 1104\u20131111.","journal-title":"Lancet Oncol"},{"issue":"3","key":"BFbjc2017269_CR13","doi-asserted-by":"publisher","first-page":"e0121071","DOI":"10.1371\/journal.pone.0121071","volume":"10","author":"S Cedr\u00e9s","year":"2015","unstructured":"Cedr\u00e9s S, Ponce-Aix S, Zugazagoitia J, Sansano I, Enguita A, Navarro-Mendivil A, Martinez-Marti A, Martinez P, Felip E (2015) Analysis of expression of programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM). PLoS One 10 (3): e0121071.","journal-title":"PLoS One"},{"key":"BFbjc2017269_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12967-014-0301-3","volume":"12","author":"S Comertpay","year":"2014","unstructured":"Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A, Baumann F, Weigel T, Friedberg J, Sugarbaker P, Krausz T, Wang E, Powers A, Gaudino G, Kanodia S, Pass HI, Parsons BL, Yang H, Carbone M (2014) Evaluation of clonal origin of malignant mesothelioma. J Transl Med 12: 301.","journal-title":"J Transl Med"},{"issue":"7","key":"BFbjc2017269_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00262-003-0388-5","volume":"52","author":"AC Diederichsen","year":"2003","unstructured":"Diederichsen AC, Hjelmborg Jv, Christensen PB, Zeuthen J, Fenger C (2003) Prognostic value of the CD4+\/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother 52 (7): 423\u2013428.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"BFbjc2017269_CR16","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1182\/blood-2009-11-253336","volume":"115","author":"ZC Ding","year":"2010","unstructured":"Ding ZC, Blazar BR, Mellor AL, Munn DH, Zhou G (2010) Chemotherapy rescues tumour driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype. Blood 115 (2): 2397\u20132406.","journal-title":"Blood"},{"key":"BFbjc2017269_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22: 329\u2013360.","journal-title":"Annu Rev Immunol"},{"issue":"5795","key":"BFbjc2017269_CR18","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohou\u00e9 F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pag\u00e8s F (2006) Type, density, and location of immune cells within human colorectal tumours predict clinical outcome. Science 313 (5795): 1960\u20131964.","journal-title":"Science"},{"issue":"6","key":"BFbjc2017269_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s13058-014-0488-5","volume":"16","author":"E Garc\u00eda-Mart\u00ednez","year":"2014","unstructured":"Garc\u00eda-Mart\u00ednez E, Gil GL, Benito AC, Gonz\u00e1lez-Billalabeitia E, Conesa MA, Garc\u00eda Garc\u00eda T, Garc\u00eda-Garre E, Vicente V, Ayala de la Pe\u00f1a F (2014) Tumour-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer. Breast Cancer Res 16 (6): 488.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"BFbjc2017269_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21 (8): 938\u2013945.","journal-title":"Nat Med"},{"issue":"1","key":"BFbjc2017269_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/bjc.2011.189","volume":"105","author":"MJ Gooden","year":"2011","unstructured":"Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105 (1): 93\u2013103.","journal-title":"Br J Cancer"},{"issue":"3","key":"BFbjc2017269_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation and cancer. Cell 140 (3): 883\u2013899.","journal-title":"Cell"},{"issue":"5","key":"BFbjc2017269_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144 (5): 646\u2013674.","journal-title":"Cell"},{"issue":"3","key":"BFbjc2017269_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumour microenvironment. Cancer Cell 21 (3): 309\u2013322.","journal-title":"Cancer Cell"},{"issue":"Suppl 2","key":"BFbjc2017269_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/2051-1426-3-S2-P161","volume":"3","author":"R Hassan","year":"2015","unstructured":"Hassan R, Alley E, Kindler H, Antonia S, Jahan T, Thomas A, Honarmand S, Murphy AL, Grous JJ, Brockstedt DG (2015) Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front line treatment for malignant pleural mesothelioma (MPM). J Immunother Cancer 3 (Suppl 2): 161.","journal-title":"J Immunother Cancer"},{"key":"BFbjc2017269_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1743-8977-6-16","volume":"6","author":"MC Jaurand","year":"2009","unstructured":"Jaurand MC, Renier A, Daubriac J (2009) Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Part Fibre Toxicol 6: 16.","journal-title":"Part Fibre Toxicol"},{"issue":"3","key":"BFbjc2017269_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1158\/1535-7163.MCT-11-0454","volume":"11","author":"RJ Kelly","year":"2012","unstructured":"Kelly RJ, Sharon E, Pastan I, Hassan R (2012) Mesothelin-targeted agents in clinical trials and in pre-clinical development. Mol Cancer Ther 11 (3): 517\u2013525.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"BFbjc2017269_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nri2729","volume":"10","author":"FE Lund","year":"2010","unstructured":"Lund FE, Randall TD (2010) Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol 10 (4): 236\u2013247.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"BFbjc2017269_CR29","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/JTO.0000000000000177","volume":"9","author":"AS Mansfield","year":"2014","unstructured":"Mansfield AS, Roden AC, Peikert T, Sheinin YM, Harrington SM, Krco CJ, Dong H, Kwon ED (2014) B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis. J Thorac Oncol 9 (7): 1036\u20131040.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"BFbjc2017269_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW (2014) Tumour associated macrophages:from mechanism to therapy. Immunity 41 (1): 49\u201361.","journal-title":"Immunity"},{"key":"BFbjc2017269_CR31","unstructured":"Rosenberg SA (2012) CAR T cell receptor immunotherapy targeting mesothelin for patients with metastatic cancer. Clinical Trials Identifier NCT01583686."},{"issue":"3","key":"BFbjc2017269_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le P\u00e9choux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W European Respiratory Society\/European Society of Thoracic Surgeons Task Force (2010) Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 35 (3): 479\u2013495.","journal-title":"Eur Respir J"},{"issue":"6024","key":"BFbjc2017269_CR33","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331 (6024): 1565\u20131570.","journal-title":"Science"},{"issue":"1","key":"BFbjc2017269_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cmi.2010.56","volume":"8","author":"W Shah","year":"2011","unstructured":"Shah W, Yan X, Jing L, Zhou Y, Chen H, Wang Y (2011) A reversed CD4\/CD8 ratio of tumour-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell Mol Immunol 8 (1): 59\u201366.","journal-title":"Cell Mol Immunol"},{"key":"BFbjc2017269_CR35","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","volume":"5","author":"B Shang","year":"2015","unstructured":"Shang B, Liu Y, Jiang SJ, Liu Y (2015) Prognostic value of tumour infiltration FOXP3+ regulatory T-cells in cancers: a systematic review and meta-analysis. Sci Rep 5: 15179.","journal-title":"Sci Rep"},{"issue":"10","key":"BFbjc2017269_CR36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43 (10): 1022\u20131025.","journal-title":"Nat Genet"},{"issue":"6","key":"BFbjc2017269_CR37","doi-asserted-by":"publisher","first-page":"e1009285","DOI":"10.1080\/2162402X.2015.1009285","volume":"4","author":"H Ujiie","year":"2015","unstructured":"Ujiie H, Kadota K, Nitadori JI, Aerts JG, Woo KM, Sima CS, Travis WD, Jones DR, Krug LM, Adusumilli PS (2015) The tumoural and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers. Oncoimmunology 4 (6): e1009285.","journal-title":"Oncoimmunology"},{"issue":"2","key":"BFbjc2017269_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.2013.639","volume":"110","author":"MJ Ward","year":"2014","unstructured":"Ward MJ, Thirdborough SM, Mellows T, Riley C, Harris S, Suchak K, Webb A, Hampton C, Patel NN, Randall CJ, Cox HJ, Jogai S, Primrose J, Piper K, Ottensmeier CH, King EV, Thomas GJ (2014) Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer. 110 (2): 489\u2013500.","journal-title":"Br J Cancer."},{"issue":"35","key":"BFbjc2017269_CR39","doi-asserted-by":"publisher","first-page":"56781","DOI":"10.18632\/oncotarget.10788","volume":"7","author":"O Wood","year":"2016","unstructured":"Wood O, Woo J, Seumois G, Savelyeva N, McCann KJ, Singh D, Jones T, Peel L, Breen MS, Ward M, Garrido Martin E, Sanchez-Elsner T, Thomas G, Vijayanand P, Woelk CH, King E, Ottensmeier C SPARC Consortium (2016) Gene expression analysis of TIL rich HPV-driven head and neck tumours reveals a distinct B-cell signature when compared to HPV independent tumours. Oncotarget 7 (35): 56781\u201356797.","journal-title":"Oncotarget"},{"issue":"10","key":"BFbjc2017269_CR40","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00262-010-0881-6","volume":"59","author":"N Yamada","year":"2010","unstructured":"Yamada N, Oizumi S, Kikuchi E, Shinagawa N, Konishi-Sakakibara J, Ishimine A, Aoe K, Gemba K, Kishimoto T, Torigoe T, Nishimura M (2010) CD8+ tumour-infiltrating lymphocytes predict favorable prognosis in malignant pleuralmesothelioma after resection. Cancer Immunol Immunother 59 (10): 1543\u20131549.","journal-title":"Cancer Immunol Immunother"},{"key":"BFbjc2017269_CR41","unstructured":"Zauderer M (2010) Randomized study of adjuvant WT1 analog peptide vaccine in patients with malignant pleural mesothelioma (MPM) after completion of combined modality therapy. Clinical Trials identifier NCT01265433."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017269","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:39:01Z","timestamp":1684417141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFbjc2017269"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.269","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"20 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}